University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

Researchers at the Markey Cancer Center have made an important discovery that could lead to new treatments for ...

Triple-negative breast cancer is an aggressive. devastating subtype of breast cancer, but researchers at UT Southwestern in ...

The study, published in the European Journal of Pharmacology, provides “new ways for the treatment of the special type of ...

Using a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to improve disease-free survival, finds a clinical trial published ...

University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

There isn't enough evidence to support the use of Merck & Co/MSD's Keytruda in combination with chemotherapy as a first-line treatment for advanced triple negative breast cancer, according to the ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

Dongan Hills resident Melissa Hickey turned her chemotherapy sessions into carnivals, movie sets and tea parties.

Triple-negative breast cancer (TNBC), a subgroup that lacks expression of hormone receptors and HER2, overlaps with basal-like breast cancer (BLBC), a subgroup that expresses cytokeratins and ...